Staff reports | Community Updates
Banner Health has named Dr. Paul Sorajja, a nationally recognized expert in interventional cardiology and valve science, to several leadership roles at Banner – University Medical Center Phoenix.
Dr. Sorajja will serve as professor of medicine, associate director of the Banner Heart Institute, director of interventional cardiology and structural heart, and the Lentsch Family director of structural heart for the Banner cardiovascular service line, according to a press release.
“We are thrilled to welcome Dr. Sorajja to Banner,” said Dr. Roderick Tung, director of Banner – University Medicine Heart Institute and division chief of cardiology at the University of Arizona College of Medicine – Phoenix. “His pioneering work in transcatheter valve therapies and extensive research experience will significantly enhance our cardiovascular services and benefit patients throughout Arizona and beyond.”
Dr. Sorajja is known for his contributions to minimally invasive procedures for valvular and structural heart disease. He was part of the team that performed the first transcatheter mitral valve replacement in the United States in 2015 and performed the first TriClip procedure in 2017.
He holds the largest experience with transcatheter tricuspid repair globally and serves as a national investigator for multiple clinical trials in transcatheter valve therapies.
He has authored more than 500 manuscripts and several books, and regularly presents at national and international medical conferences. Dr. Sorajja earned his medical degree from Mayo Medical School and completed his residency and fellowship at the Mayo Graduate School of Medicine.
He joined the Mayo Clinic staff in 2006 and became a professor of medicine in 2012. In 2013, he joined the Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital, where he directed the Center for Valve and Structural Heart Disease and held the Roger L. and Lynn C. Headrick Family Chair of the Valve Science Center.
Throughout his career, Dr. Sorajja has served on national committees focused on valvular heart disease and hypertrophic cardiomyopathy.
